AAAAAA

   
Results: 1-20 |
Results: 20
THE USE OF IMMUNIHISTOCHEMICAL STAINING (IHS) OF TYPE-IV COLLAGEN (TIVC) AND SMOOTH-MUSCLE ACTIN (SMA) IN THE DIFFERENTIAL-DIAGNOSIS OF BREAST-LESIONS
Authors: BOSE S DEROSA CM OZZELLO L
Citation: S. Bose et al., THE USE OF IMMUNIHISTOCHEMICAL STAINING (IHS) OF TYPE-IV COLLAGEN (TIVC) AND SMOOTH-MUSCLE ACTIN (SMA) IN THE DIFFERENTIAL-DIAGNOSIS OF BREAST-LESIONS, Modern pathology, 11(1), 1998, pp. 17-17
CONJUGATION OF INTERFERON-ALPHA TO A HUMANIZED MONOCLONAL-ANTIBODY (HUBRE-3VL) ENHANCES THE SELECTIVE LOCALIZATION AND ANTITUMOR EFFECTS OFINTERFERON IN BREAST-CANCER XENOGRAFTS
Authors: OZZELLO L BLANK EW DEROSA CM CERIANI RL TOLO H KAUPPINEN HL CANTELL K
Citation: L. Ozzello et al., CONJUGATION OF INTERFERON-ALPHA TO A HUMANIZED MONOCLONAL-ANTIBODY (HUBRE-3VL) ENHANCES THE SELECTIVE LOCALIZATION AND ANTITUMOR EFFECTS OFINTERFERON IN BREAST-CANCER XENOGRAFTS, Breast cancer research and treatment, 48(2), 1998, pp. 135-147
THE USE OF IMMUNOHISTOCHEMICAL STAINING (IHS) OF TYPE-IV COLLAGEN (TIVC) AND SMOOTH-MUSCLE ACTIN (SMA) IN THE DIFFERENTIAL-DIAGNOSIS OF BREAST-LESIONS
Authors: BOSE S DEROSA CM OZZELLO L
Citation: S. Bose et al., THE USE OF IMMUNOHISTOCHEMICAL STAINING (IHS) OF TYPE-IV COLLAGEN (TIVC) AND SMOOTH-MUSCLE ACTIN (SMA) IN THE DIFFERENTIAL-DIAGNOSIS OF BREAST-LESIONS, Laboratory investigation, 78(1), 1998, pp. 80-80
EVIDENCE OF VASCULAR GROWTH-ASSOCIATED WITH LASER TREATMENT OF NORMALCANINE MYOCARDIUM
Authors: KOHMOTO T DEROSA CM YAMAMOTO N FISHER PE FAILEY P SMITH CR BURKHOFF D
Citation: T. Kohmoto et al., EVIDENCE OF VASCULAR GROWTH-ASSOCIATED WITH LASER TREATMENT OF NORMALCANINE MYOCARDIUM, The Annals of thoracic surgery, 65(5), 1998, pp. 1360-1367
IS APROTININ INDICATED FOR REOPERATIVE VALVULAR SURGERY
Authors: GOLDSTEIN DJ DEROSA CM SELDOMRIDGE JA WEINBERG AD OZ MC SMITH CR
Citation: Dj. Goldstein et al., IS APROTININ INDICATED FOR REOPERATIVE VALVULAR SURGERY, Journal of heart valve disease, 6(1), 1997, pp. 88-92
SURGICAL AND LONG-TERM MORTALITY-RATES AFTER CABG SURGERY DO NOT VARYBY GENDER AMONG HIGH-RISK PATIENTS
Authors: HAAS TS BISHOP V BLOOMFIELD DM ROLNITZKY L DEROSA CM
Citation: Ts. Haas et al., SURGICAL AND LONG-TERM MORTALITY-RATES AFTER CABG SURGERY DO NOT VARYBY GENDER AMONG HIGH-RISK PATIENTS, Circulation, 96(8), 1997, pp. 2073-2073
ASSESSMENT OF TRANSMYOCARDIAL PERFUSION IN ALLIGATOR HEARTS
Authors: KOHMOTO T ARGENZIANO M YAMAMOTO N VLIET KA GU AG DEROSA CM FISHER PE SPOTNITZ HM BURKHOFF D SMITH CR
Citation: T. Kohmoto et al., ASSESSMENT OF TRANSMYOCARDIAL PERFUSION IN ALLIGATOR HEARTS, Circulation, 95(6), 1997, pp. 1585-1591
HISTOLOGIC ANALYSIS OF TRANSMYOCARDIAL CHANNELS - COMPARISON OF CO2 AND HOLMIUM-YAG LASERS
Authors: FISHER PE KHOMOTO T DEROSA CM SPOTNITZ HM SMITH CR BURKHOFF D
Citation: Pe. Fisher et al., HISTOLOGIC ANALYSIS OF TRANSMYOCARDIAL CHANNELS - COMPARISON OF CO2 AND HOLMIUM-YAG LASERS, The Annals of thoracic surgery, 64(2), 1997, pp. 466-472
PHYSIOLOGY, HISTOLOGY, AND 2-WEEK MORPHOLOGY OF ACUTE TRANSMYOCARDIALCHANNELS MADE WITH A CO2-LASER
Authors: KOHMOTO T FISHER PE GU A ZHU SM DEROSA CM SMITH CR BURKHOFF D
Citation: T. Kohmoto et al., PHYSIOLOGY, HISTOLOGY, AND 2-WEEK MORPHOLOGY OF ACUTE TRANSMYOCARDIALCHANNELS MADE WITH A CO2-LASER, The Annals of thoracic surgery, 63(5), 1997, pp. 1275-1283
APOPTOSIS CONTRIBUTES TO MYOCYTE LOSS LATE AFTER MYOCARDIAL-INFARCTION IN RATS
Authors: RAVALLI S CAI BL KOHMOTO T SZABOLCS M DEROSA CM UZUN G PACKER M BURKHOFF D
Citation: S. Ravalli et al., APOPTOSIS CONTRIBUTES TO MYOCYTE LOSS LATE AFTER MYOCARDIAL-INFARCTION IN RATS, Circulation, 94(8), 1996, pp. 181-181
HISTOLOGIC APPEARANCE OF TRANSMYOCARDIAL LASER CHANNELS AFTER 4-1 2 WEEKS/
Authors: BURKHOFF D FISHER PE APFELBAUM M KOHMOTO T DEROSA CM SMITH CR
Citation: D. Burkhoff et al., HISTOLOGIC APPEARANCE OF TRANSMYOCARDIAL LASER CHANNELS AFTER 4-1 2 WEEKS/, The Annals of thoracic surgery, 61(5), 1996, pp. 1532-1534
SAFETY OF REPEAT APROTININ ADMINISTRATION FOR LVAD RECIPIENTS UNDERGOING CARDIAC TRANSPLANTATION
Authors: GOLDSTEIN DJ OZ MC SMITH CR FRIEDLANDER JP DEROSA CM MONGERO LB DELPHIN E
Citation: Dj. Goldstein et al., SAFETY OF REPEAT APROTININ ADMINISTRATION FOR LVAD RECIPIENTS UNDERGOING CARDIAC TRANSPLANTATION, The Annals of thoracic surgery, 61(2), 1996, pp. 692-695
REGRESSION OF HUMAN BREAST-CANCER XENOGRAFTS IN RESPONSE TO INTRALESIONAL TREATMENT WITH INTERFERON-ALPHA AND INTERFERON-GAMMA POTENTIATED BY TUMOR-NECROSIS-FACTOR
Authors: OZZELLO L DEROSA CM CANTELL K KAUPPINEN HL HABIF DV
Citation: L. Ozzello et al., REGRESSION OF HUMAN BREAST-CANCER XENOGRAFTS IN RESPONSE TO INTRALESIONAL TREATMENT WITH INTERFERON-ALPHA AND INTERFERON-GAMMA POTENTIATED BY TUMOR-NECROSIS-FACTOR, Journal of interferon & cytokine research, 15(10), 1995, pp. 839-848
UP-REGULATION OF A TUMOR-ASSOCIATED ANTIGEN (TAG-72) BY INTERFERON-ALPHA AND INTERFERON-GAMMA IN PATIENTS WITH CUTANEOUS BREAST-CANCER RECURRENCES
Authors: OZZELLO L DEROSA CM HABIF DV CANTELL K PESTKA S
Citation: L. Ozzello et al., UP-REGULATION OF A TUMOR-ASSOCIATED ANTIGEN (TAG-72) BY INTERFERON-ALPHA AND INTERFERON-GAMMA IN PATIENTS WITH CUTANEOUS BREAST-CANCER RECURRENCES, International journal of oncology, 6(5), 1995, pp. 985-991
REGRESSION OF SKIN RECURRENCES OF BREAST CARCINOMAS TREATED WITH INTRALESIONAL INJECTIONS OF NATURAL INTERFERON-ALPHA AND INTERFERON-GAMMA
Authors: HABIF DV OZZELLO L DEROSA CM CANTELL K LATTES R
Citation: Dv. Habif et al., REGRESSION OF SKIN RECURRENCES OF BREAST CARCINOMAS TREATED WITH INTRALESIONAL INJECTIONS OF NATURAL INTERFERON-ALPHA AND INTERFERON-GAMMA, Cancer investigation, 13(2), 1995, pp. 165-172
SAFETY AND EFFICACY OF APROTININ UNDER CONDITIONS OF DEEP HYPOTHERMIAAND CIRCULATORY ARREST
Authors: GOLDSTEIN DJ DEROSA CM MONGERO LB WEINBERG AD MICHLER RE ROSE EA OZ MC SMITH CR
Citation: Dj. Goldstein et al., SAFETY AND EFFICACY OF APROTININ UNDER CONDITIONS OF DEEP HYPOTHERMIAAND CIRCULATORY ARREST, Journal of thoracic and cardiovascular surgery, 110(6), 1995, pp. 1615-1621
USE OF APROTININ IN LVAD RECIPIENTS REDUCES BLOOD-LOSS, BLOOD USE, AND PERIOPERATIVE MORTALITY
Authors: GOLDSTEIN DJ SELDOMRIDGE JA CHEN JM CATANESE KA DEROSA CM WEINBERG AD SMITH CR ROSE EA LEVIN HR OZ MC
Citation: Dj. Goldstein et al., USE OF APROTININ IN LVAD RECIPIENTS REDUCES BLOOD-LOSS, BLOOD USE, AND PERIOPERATIVE MORTALITY, The Annals of thoracic surgery, 59(5), 1995, pp. 1063-1068
SAFETY OF APROTININ IN PROFOUND HYPOTHERMIA AND CIRCULATORY ARREST
Authors: SMITH CR MONGERO LB DEROSA CM MICHLER RE OZ MC
Citation: Cr. Smith et al., SAFETY OF APROTININ IN PROFOUND HYPOTHERMIA AND CIRCULATORY ARREST, The Annals of thoracic surgery, 58(2), 1994, pp. 606-607
THE USE OF NATURAL INTERFERON-ALPHA CONJUGATED TO A MONOCLONAL-ANTIBODY ANTIMAMMARY EPITHELIAL MUCIN (MC5) FOR THE TREATMENT OF HUMAN BREAST-CANCER XENOGRAFTS
Authors: OZZELLO L DEROSA CM BLANK EW CANTELL K CERIANI RL HABIF DV
Citation: L. Ozzello et al., THE USE OF NATURAL INTERFERON-ALPHA CONJUGATED TO A MONOCLONAL-ANTIBODY ANTIMAMMARY EPITHELIAL MUCIN (MC5) FOR THE TREATMENT OF HUMAN BREAST-CANCER XENOGRAFTS, Breast cancer research and treatment, 25(3), 1993, pp. 265-276
MORPHOLOGICAL CORNEAL EPITHELIAL CHANGES AFTER TOPICAL INSTILLATION OF DICLOPHENAC EYE DROPS
Authors: VERGES C ACOSTA JC DEROSA CM TORTRAS M RUIZ C DELMAR H
Citation: C. Verges et al., MORPHOLOGICAL CORNEAL EPITHELIAL CHANGES AFTER TOPICAL INSTILLATION OF DICLOPHENAC EYE DROPS, Investigative ophthalmology & visual science, 33(4), 1992, pp. 997-997
Risultati: 1-20 |